litlas
Log inCreate account

Roy L. Silverstein

Active 1984–2024

107
Papers
27,594
Citations
88
h-index
106
i10-index

Citations

Citations per year for Roy L. Silverstein1984: 1 citations1985: 8 citations1986: 21 citations1987: 35 citations1988: 47 citations1989: 58 citations1990: 54 citations1991: 56 citations1992: 42 citations1993: 42 citations1994: 30 citations1995: 38 citations1996: 71 citations1997: 72 citations1998: 90 citations1999: 130 citations2000: 240 citations2001: 271 citations2002: 293 citations2003: 279 citations2004: 279 citations2005: 243 citations2006: 225 citations2007: 320 citations2008: 312 citations2009: 298 citations2010: 308 citations2011: 291 citations2012: 261 citations2013: 259 citations2014: 220 citations2015: 182 citations2016: 225 citations2017: 270 citations2018: 242 citations2019: 667 citations2020: 885 citations2021: 850 citations2022: 789 citations2023: 623 citations2024: 890 citations2025: 462 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,472 citing papers, 32% of this breakdownChina: 1,599 citing papers, 14.7% of this breakdownUnited Kingdom: 612 citing papers, 5.6% of this breakdownGermany: 529 citing papers, 4.9% of this breakdownCanada: 397 citing papers, 3.7% of this breakdownItaly: 393 citing papers, 3.6% of this breakdownFrance: 345 citing papers, 3.2% of this breakdownJapan: 313 citing papers, 2.9% of this breakdownNetherlands: 282 citing papers, 2.6% of this breakdownAustralia: 239 citing papers, 2.2% of this breakdownSpain: 208 citing papers, 1.9% of this breakdownSweden: 175 citing papers, 1.6% of this breakdown
0%32%Other 21.1%

Institutions

Fields

  • Medicine37.5%
  • Biochemistry, Genetics and Molecular Biology36.4%
  • Immunology and Microbiology18.7%
  • Neuroscience3.4%
  • Nursing1.1%
  • Agricultural and Biological Sciences0.8%
  • Other2.1%

Topics

  • Gut microbiota and health3.5%
  • Immune cells in cancer2.8%
  • Atherosclerosis and Cardiovascular Diseases2.7%
  • Peroxisome Proliferator-Activated Receptors2.6%
  • Phagocytosis and Immune Regulation2.1%
  • Immune Cell Function and Interaction2%
  • Other84.3%

Coauthors

All papers

Open in search
  1. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

    Authors: Lin Li, Elin Org, Joseph A. DiDonato, R. Balfour Sartor, W.H. Wilson Tang, Roy L. Silverstein, Xiaoming Fu, Weifei Zhu, Nilaksh Gupta, Jill C. Gregory, J. Mark Brown, Aldons J. Lusis, Stanley L. Hazen, Margarete Mehrabian, Thomas M. McIntyre, Zeneng Wang, Jennifer A. Buffa, Yuping Wu - Cell 2016 cited by 1,946

  2. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

    Authors: Haiping Wang, Fabien Franco, Yao-Chen Tsui, Xin Xie, Marcel P. Trefny, Roberta Zappasodi, Syed Raza Mohmood, Juan Fernández-García, Chin-Hsien Tsai, Isabell Schulze, Florence Picard, Etienne Meylan, Roy L. Silverstein, Ira J. Goldberg, Sarah‐Maria Fendt, Jedd D. Wolchok, Taha Merghoub, Camilla Jandus, Alfred Zippelius, Ping‐Chih Ho - Nature Immunology 2020 cited by 647

  3. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

    Authors: Yiliang Chen, Jue Zhang, Weiguo Cui, Roy L. Silverstein - The Journal of Experimental Medicine 2022 cited by 433

  4. CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior

    Authors: Roy L. Silverstein, Maria Febbraio - Science Signaling 2009 cited by 1,248

  5. Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses

    Authors: Yiliang Chen, Moua Yang, Wenxin Huang, Wenjing Chen, Yiqiong Zhao, Marie L. Schulte, Peter J. Volberding, Zachary J. Gerbec, Michael T. Zimmermann, Atefeh Zeighami, Wendy Demos, Jue Zhang, Darcy A. Knaack, Brian C. Smith, Weiguo Cui, Subramaniam Malarkannan, Komal Sodhi, Joseph I. Shapiro, Zijian Xie, Daisy Sahoo, Roy L. Silverstein - Circulation Research 2019 cited by 260

  6. Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages

    Authors: Vidya Kunjathoor, Maria Febbraio, Eugene A. Podrez, Kathryn J. Moore, Lorna P. Andersson, Stephanie L. Koehn, Jeongmi S. Rhee, Roy L. Silverstein, Henry F. Hoff, Mason W. Freeman - Journal of Biological Chemistry 2002 cited by 1,022

  7. Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression

    Authors: James S. Hale, Balint Otvos, Maksim Sinyuk, Alvaro G. Alvarado, Masahiro Hitomi, Kevin B. Stoltz, Qiulian Wu, William Flavahan, Bruce S. Levison, Mette L. Johansen, David Schmitt, Janna M. Neltner, Ping Huang, Bin Ren, Andrew E. Sloan, Roy L. Silverstein, Candece L. Gladson, Joseph A. DiDonato, J. Mark Brown, Thomas M. McIntyre, Stanley L. Hazen, Craig Horbinski, Jeremy N. Rich, Justin D. Lathia - Stem Cells 2014 cited by 258

  8. Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice

    Authors: Chris T. Coburn, F. F. Knapp, Maria Febbraio, A.L. Beets, Roy L. Silverstein, Nada A. Abumrad - Journal of Biological Chemistry 2000 cited by 717

  9. Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis

    Authors: Jie Zhou, Maria Febbraio, Taira Wada, Yonggong Zhai, Ramalinga Kuruba, Jinhan He, Jung Hoon Lee, Shaheen Khadem, Songrong Ren, Song Li, Roy L. Silverstein, Wen Xie - Gastroenterology 2007 cited by 610

  10. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

    Authors: Maria Febbraio, David P. Hajjar, Roy L. Silverstein - Journal of Clinical Investigation 2001 cited by 1,146

  11. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

    Authors: Maria Febbraio, Eugene A. Podrez, Jonathan D. Smith, David P. Hajjar, Stanley L. Hazen, Henry F. Hoff, Kavita Sharma, Roy L. Silverstein - Journal of Clinical Investigation 2000 cited by 1,039

  12. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation

    Authors: Shaik O. Rahaman, David Lennon, Maria Febbraio, Evgeny Podrez, Stanley L. Hazen, Roy L. Silverstein - Cell Metabolism 2006 cited by 505

  13. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

    Authors: Benilde Jiménez, Olga V. Volpert, Susan E. Crawford, Maria Febbraio, Roy L. Silverstein, Noël Bouck - Nature Medicine 2000 cited by 1,021

  14. Exosome poly‐ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro‐atherothombotic cellular functions

    Authors: Sowmya Srikanthan, Wei Li, Roy L. Silverstein, Thomas M. McIntyre - Journal of Thrombosis and Haemostasis 2014 cited by 133

  15. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

    Authors: Eugene A. Podrez, Tatiana V. Byzova, Maria Febbraio, Robert G. Salomon, Yi Ma, Manojkumar Valiyaveettil, Eugenia Poliakov, Mingjiang Sun, Paula J. Finton, Brian R. Curtis, Juhua Chen, Renliang Zhang, Roy L. Silverstein, Stanley L. Hazen - Nature Medicine 2007 cited by 502

  16. Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells

    Authors: Michael E. Greenberg, Mingjiang Sun, Renliang Zhang, Maria Febbraio, Roy L. Silverstein, Stanley L. Hazen - The Journal of Experimental Medicine 2006 cited by 417

  17. Intracellular tPA–PAI-1 interaction determines VLDL assembly in hepatocytes

    Authors: Wen Dai, Heng Zhang, Hayley Lund, Ziyu Zhang, Mark Castleberry, Maya Rodriguez, George Kuriakose, Sweta Gupta, Magdalena Lewandowska, Hayley R. Powers, Swati Valmiki, Jieqing Zhu, Amy D. Shapiro, M. Mahmood Hussain, José A. López, Mary G. Sorci‐Thomas, Roy L. Silverstein, Henry N. Ginsberg, Daisy Sahoo, Ira Tabas, Ze Zheng - Science 2023 cited by 45

  18. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling

    Authors: David J. Kennedy, Sai Kuchibhotla, Kristen M. Westfall, Roy L. Silverstein, Richard E. Morton, Maria Febbraio - Cardiovascular Research 2010 cited by 193

  19. Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes

    Authors: Matthew L. Albert, S. Frieda A. Pearce, Loise M. Francisco, Birthe Sauter, Pampa Roy, Roy L. Silverstein, Nina Bhardwaj - The Journal of Experimental Medicine 1998 cited by 1,214

  20. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima

    Authors: Young Mi Park, Maria Febbraio, Roy L. Silverstein - Journal of Clinical Investigation 2008 cited by 399

  21. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells

    Authors: Ling-Yun Chu, Devi Prasadh Ramakrishnan, Roy L. Silverstein - Blood 2013 cited by 164

  22. Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer

    Authors: Gang Xin, Chen Yao, Paytsar Topchyan, Moujtaba Y. Kasmani, Robert Burns, Peter J. Volberding, Xiaopeng Wu, Alexandra Cohn, Yiliang Chen, Chien‐Wei Lin, Ping‐Chih Ho, Roy L. Silverstein, Michael B. Dwinell, Weiguo Cui - Cancer Immunology Research 2021 cited by 84

  23. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

    Authors: David W. Dawson, S. Frieda A. Pearce, Ruiqin Zhong, Roy L. Silverstein, William A. Frazier, Noël Bouck - The Journal of Cell Biology 1997 cited by 678

  24. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

    Authors: Eugene A. Podrez, Maria Febbraio, Nader Sheibani, David Schmitt, Roy L. Silverstein, David P. Hajjar, Peter A. Cohen, William A. Frazier, Henry F. Hoff, Stanley L. Hazen - Journal of Clinical Investigation 2000 cited by 451